KalVista Pharmaceuticals
KALV
KALV
91 hedge funds and large institutions have $234M invested in KalVista Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 29 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 94 → 91 (-3)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
34% less capital invested
Capital invested by funds: $357M → $234M (-$122M)
Holders
91
Holding in Top 10
2
Calls
$1.1M
Puts
$90K
Top Buyers
| 1 | +$23M | |
| 2 | +$19.7M | |
| 3 | +$11.3M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$9.44M |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$8.11M |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$11.3M | |
| 3 | -$4.59M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$4.58M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$4.29M |